4-Methyl-1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)furan-2-yl)-1H-pyrazole

Catalog No. :
ACXEXT966
CAS No. :
2223031-76-1
Molecular Formula :
C14H19BN2O3
Molecular Weight :
274.13

IUPAC Name:4-methyl-1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)furan-2-yl)-1H-pyrazole

4-Methyl-1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)furan-2-yl)-1H-pyrazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methyl-1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)furan-2-yl)-1H-pyrazole
IUPAC Name4-methyl-1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)furan-2-yl)-1H-pyrazole
Molecular FormulaC14H19BN2O3
Molecular Weight274.13
SMILESCC1=CN(N=C1)C(O2)=CC=C2B3OC(C)(C)C(C)(C)O3
InChI KeyORIACCXYQCZOAN-UHFFFAOYSA-N
Synonym5-(4-Methyl-1H-pyrazol-1-yl)furan-2-boronic acid pinacol ester;1H-Pyrazole, 4-methyl-1-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-furanyl]-
CAS No.2223031-76-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACXEXT966 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXEXT966 route product structure diagram
    ACXEXT9662223031-76-1
Inquiry

2. ACXEXT966 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJYKC972 route compound structure diagram
    ACJYKC97256010-88-9 In Stock
  4. Then
  5. ACXEXT966 route product structure diagram
    ACXEXT9662223031-76-1
Inquiry

Comments (0)